Mayla Hsu, Ph.D, joined Global Lyme Alliance in 2015 as its in-house Science Officer and is now Director of Research and Science. She manages GLA’s research grant program, working with the Scientific Advisory Board and creating viable partnerships to help advance the development of a reliable diagnostic test, effective treatments and ultimately a cure for Lyme.
Mayla, who previously worked as a science writer at the Rockefeller University in New York, has a background in medical virology. She obtained her Ph.D. in 2000 from McGill University in Montreal, Canada, studying the mechanisms of drug resistance in human immunodeficiency virus (HIV).
She followed this with post-doctoral studies at the Rockefeller University, working on HIV transmission, where her interest in host-pathogen interactions developed. She then decided to pursue more translational research and moved to Bristol-Myers Squibb, where she joined a team developing screening assays to look for new compounds targeting HIV and hepatitis viruses.